Worldwide Study Finder

Loading registry information…

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 14 on this page, newest registry updates first. Search checked 2026-11-08 20:45 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

DILIPO (DILutIonal HyPOnatremia)

ClinicalTrials.gov · NCT00274326 · Registry updated: 2008-09-15

Condition / research focus: Congestive Heart Failure
Sponsor: Sanofi
Countries with listed sites: Argentina · Australia · Belgium · Canada · Chile · Denmark · Greece · Hungary · Israel · Poland · Portugal · Romania · South Africa · Sweden · United States
Registry dates and results: Start: 2005-05. Completion: 2007-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

SR121463B (drug)

Where the study takes place — 15 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Sanofi-Aventis Administrative Office
Bridgewater, New Jersey, United States
Site recruitment: Not reported

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Phase 2CompletedINTERVENTIONAL

Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).

ClinicalTrials.gov · NCT00032747 · Registry updated: 2008-06-17

Condition / research focus: Chronic Heart Failure
Sponsor: Sanofi
Countries with listed sites: Canada · United Kingdom · United States
Registry dates and results: Start: 2001-08. Completion: 2003-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin V2 Receptor Antagonist (drug)

Where the study takes place — 9 listed sites

University of Alabama at Birmingham
Birmingham, Alabama, United States
Site recruitment: Not reported
Emory University
Atlanta, Georgia, United States
Site recruitment: Not reported
University of Iowa Hospital and Clinics
Iowa City, Iowa, United States
Site recruitment: Not reported
University of Maryland School of Medicine
Baltimore, Maryland, United States
Site recruitment: Not reported
Brian LGH Heart Institute
Lincoln, Nebraska, United States
Site recruitment: Not reported
The Lindner Clinical Trial Center
Cincinnati, Ohio, United States
Site recruitment: Not reported
MUSC/Division Cardiology
Charleston, South Carolina, United States
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Laval, Canada
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Guildford Surrey, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Worldwide Study Finder

Worldwide Study Finder

Find a study

Registry search results

DILIPO (DILutIonal HyPOnatremia)

Explore the world’s study registries

Worldwide

Africa

Americas

Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).

Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea

Noradrenalin vs Terlipressin in Hepatorenal Syndrome

Continuous Infusion of Terlipressin in Septic Shock

Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed

Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin

Treatment and Management of Women With Bleeding Disorders

Comparison of Vasopressin and Other Pressors in Septic Shock

Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites

Study of Novel Types of Familial Diabetes Insipidus

Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus

Asia

Middle East

Europe

Oceania